Literature DB >> 10332075

Solid lipid nanoparticles as carriers of hydrocortisone and progesterone complexes with beta-cyclodextrins.

R Cavalli1, E Peira, O Caputo, M R Gasco.   

Abstract

Inclusion complexes of hydrocortisone and progesterone were formed with beta-cyclodextrin or 2-hydroxypropyl-beta-cyclodextrin. The formation of the complexes was confirmed by differential scanning calorimetry (DSC). The inclusion complexes were incorporated in two types of solid lipid nanoparticles (SLN). In the presence of the complexes the sizes of SLN remained below 100 nm. DSC analysis showed that hydrocortisone and progesterone are dispersed in SLN in an amorphous state. Using the beta-cyclodextrin complexes the incorporation of the more hydrophilic drug, hydrocortisone, was higher than that of progesterone. Release of hydrocortisone and progesterone from SLN was lower when they were incorporated as inclusion complexes than as free molecules. Copyright.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10332075     DOI: 10.1016/s0378-5173(99)00066-6

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  12 in total

Review 1.  Advanced technologies for oral controlled release: cyclodextrins for oral controlled release.

Authors:  Paulo José Salústio; Patrícia Pontes; Claúdia Conduto; Inês Sanches; Catarina Carvalho; João Arrais; Helena M Cabral Marques
Journal:  AAPS PharmSciTech       Date:  2011-09-27       Impact factor: 3.246

Review 2.  Cyclodextrins in drug delivery: an updated review.

Authors:  Rajeswari Challa; Alka Ahuja; Javed Ali; R K Khar
Journal:  AAPS PharmSciTech       Date:  2005-10-14       Impact factor: 3.246

3.  Sickness behaviors following medial frontal cortical contusions in male rats.

Authors:  Kimberly J Grossman; Cynthia W Goss; Donald G Stein
Journal:  Behav Brain Res       Date:  2010-10-07       Impact factor: 3.332

Review 4.  Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives.

Authors:  Melike Uner; Gülgün Yener
Journal:  Int J Nanomedicine       Date:  2007

5.  Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery.

Authors:  Patrícia Severino; Tatiana Andreani; Ana Sofia Macedo; Joana F Fangueiro; Maria Helena A Santana; Amélia M Silva; Eliana B Souto
Journal:  J Drug Deliv       Date:  2011-11-24

6.  Design of cationic nanostructured heterolipid matrices for ocular delivery of methazolamide.

Authors:  John Youshia; Amany O Kamel; Abdelhameed El Shamy; Samar Mansour
Journal:  Int J Nanomedicine       Date:  2012-05-17

7.  Evaluation of the bioavailability of hydrocortisone when prepared as solid dispersion.

Authors:  Mohammad A Altamimi; Ehab M Elzayat; Wajhul Qamar; Sultan M Alshehri; Abdelrahman Y Sherif; Nazrul Haq; Faiyaz Shakeel
Journal:  Saudi Pharm J       Date:  2019-03-07       Impact factor: 4.330

8.  Effects of spray-drying on w/o/w multiple emulsions prepared from a stearic acid matrix.

Authors:  Nichrous Mlalila; Hulda Swai; Lonji Kalombo; Askwar Hilonga
Journal:  Nanotechnol Sci Appl       Date:  2014-12-01

9.  Solid Lipid Nanoparticles Loaded with Glucocorticoids Protect Auditory Cells from Cisplatin-Induced Ototoxicity.

Authors:  Blanca Cervantes; Lide Arana; Silvia Murillo-Cuesta; Marina Bruno; Itziar Alkorta; Isabel Varela-Nieto
Journal:  J Clin Med       Date:  2019-09-14       Impact factor: 4.241

10.  Nano intervention in topical delivery of corticosteroid for psoriasis and atopic dermatitis-a systematic review.

Authors:  Kshitya Shetty; Atul P Sherje
Journal:  J Mater Sci Mater Med       Date:  2021-07-31       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.